Recurrent venous thromboembolism
Assessing the risk of recurrent venous thromboembolism – a practical approach
... Abstract: Recurrent venous thromboembolism (VTE) is associated with increased morbidity and ...the venous thromboembolic event, and with a smaller effect in terms of secondary prevention of ...
9
Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis
... of venous thromboembolism (VTE) and the risk is further elevated after a primary ...of recurrent events, extended prophylaxis with vitamin K antagonists (VKA) is available for ...of Recurrent ...
9
<p>Case Report: Klippel-Trenaunay Syndrome – Recurrent Venous Thromboembolism and Vascular Malformation</p>
... Klippel-Trenaunay Syndrome (KTS) is a rare congenital disorder characterized by a triad of varicosities, cutaneous capillary malformations, and soft tissue or bone hypertrophy of one or more limbs. Other clinical ...
6
Association of recurrent venous thromboembolism and circulating microRNAs
... has been followed over time. The subjects were selected from a prospective population-based cohort study at Skåne University Hospital in Sweden; Malmö Thrombo- philia Study (MATS). MATS included a total of 1465 ...
12
COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study
... for venous thromboembolism (VTE) [1], and up to 20% of patients with active cancer will develop VTE, depending on the cancer type, stage and treatment [2, ...of recurrent events and bleeding during ...
9
Recurrent venous thromboembolism patients form clots with lower elastic modulus than those with non-recurrent disease.
... Background: Venous thromboembolism (VTE) is associated with a high risk of recurrent events after withdrawal of ...with recurrent VTE (rVTE) and those with non-recurrent VTE ...
9
Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post treatment of first unprovoked VTE
... The HERDOO2 model was markedly underpowered, having collected information on 69 predictors and con- sidered at least 36 of these. There were only 91 recurrent events (see table 2), meaning the HERDOO2 model only ...
17
Prevention, diagnosis and treatment of venous thromboembolism
... Dosage of low molecular weight heparins for VTE prophylaxis is presented in Table 6. [10] Unfractionated heparin therapy requires monitoring of the value of koalin-cephalin time (APTT). It should be extended by 1.5-2.5 ...
7
Long-Term Anticoagulant Therapy: Clinical Decision and Therapeutic Strategies. Kenneth A. Bauer, MD Harvard Medical School Boston, MA USA
... Rodger M (PI): REVERSE (REcurrent VEnous Thromboembolism Risk Stratification Evaluation) II: Men continue and women with 2 of Hyperpigmentation, Erythema, Redness, D-Dimer > 250, Ob[r] ...
46
Prognostic assessment for patients with cancer and incidental pulmonary embolism
... of recurrent venous thromboembolism in patients with cancer (clinical trial acronym); CT: Computed Tomography; DVT: Deep Vein Thrombosis; ECOG: Eastern Cooperative Oncology Group; Hb: Haemoglobin; ...
10
Update on the clinical use of the low-molecular-weight heparin, parnaparin
... of venous thromboembolism (VTE), and for the treatment of acute coronary syndromes (ACS) and peripheral arterial occlusive disease (PAOD), and for the management of chronic venous disorders (CVD), ...
13
The diagnosis and treatment of venous thromboembolism in Asian patients
... for Venous Thromboembolism in the Acute Hospital Care Setting; INR: International normalized ratio; JCS: Japanese Circulation Society; LMWH: Low-molecular-weight heparin; NOAC: Non-vitamin K antagonist oral ...
12
Direct oral anticoagulants and venous thromboembolism
... in Venous Thromboembolism), a multicentre, prospective, noninterventional study of 5142 patients with DVT, have been published ...of recurrent VTE did not differ between the treatment groups (HR ...
8
The effects of obesity on venous thromboembolism: A review
... of recurrent VTE was ...of recurrent VTE (OR = ...for recurrent VTE (OR = ...of recurrent VTE that fol- lowed 98 patients and for 117 months after an initial episode of spontaneous VTE ...of ...
11
Prediction of long-term complications of venous thromboembolism
... established by screening is indeed associated with a better treatment outcome and prognosis, and 2) whether screening algorithms for CTEPH prove to be cost-effective. The incidence of CTEPH in the clinical course of ...
175
Venous thromboembolism in head and neck cancer surgery
... Venous thromboembolism is a major source of peri- operative morbidity and mortality that is largely pre- ventable. It accounts for approximately 10 % of hospital deaths annually [3], and patients that ...
8
Role of Dyslipidemia and Statins in Venous Thromboembolism
... ASA = acetylsahcyhc acid, CABG = coronary artery bypass graft, Cl = confidence mterval, DVT = deep vem thrombosis, FVII C = factor VII coagu lant, HOL C = high density-hpoprotem choleste[r] ...
5
The role of dyslipidemia and statins in venous thromboembolism
... cause venous endothelial dysfunction in healthy adults [29], while postprandial lipemia has been associated with transient changes in factor VII coagulant (FVII:C) activity in humans [30], suggesting a temporary ...
6
Cardiovascular risk factors associated with venous thromboembolism
... Cardiovascular Risk Factors Associated With Venous Thromboembolism Institute for Health and Welfare, Helsinki, Finland Salomaa; Ludwig Maximilian University of Munich, Munich, Germany Me[r] ...
11
Venous thromboembolism prophylaxis strategies for people undergoing elective total knee replacement: a systematic review and network meta-analysis
... Hospital-acquired venous thromboembolism (VTE) is a major patient safety concern.(1, 2) It is defined as any deep-vein thrombosis (DVT) or pulmonary thromboembolism (PE) events that occu[r] ...
21